As of 2026-10-01, the Relative Valuation of Regenxbio Inc (RGNX) is (87.68) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.53 USD, the upside of Regenxbio Inc based on Relative Valuation is -1264.4%.
The range of the Relative Valuation is (81.01) - (93.42) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 26.0x - 30.1x | 28.0x |
| Forward P/E multiples | 26.1x - 30.8x | 28.4x |
| Fair Price | (81.01) - (93.42) | (87.68) |
| Upside | -1175.8% - -1340.6% | -1264.4% |
| Date | P/E |
| 2026-09-30 | -2.43 |
| 2026-09-29 | -2.40 |
| 2026-09-28 | -2.41 |
| 2026-09-25 | -2.38 |
| 2026-09-24 | -2.33 |
| 2026-09-23 | -2.42 |
| 2026-09-22 | -2.63 |
| 2026-09-21 | -2.54 |
| 2026-09-18 | -2.59 |
| 2026-09-17 | -2.65 |
| 2026-09-16 | -2.57 |
| 2026-09-15 | -2.56 |
| 2026-09-14 | -2.80 |
| 2026-09-11 | -2.75 |
| 2026-09-10 | -2.76 |
| 2026-09-09 | -2.81 |
| 2026-09-08 | -2.82 |
| 2026-09-04 | -2.88 |
| 2026-09-03 | -2.96 |
| 2026-09-02 | -3.09 |
| 2026-09-01 | -3.00 |
| 2026-08-31 | -3.06 |
| 2026-08-28 | -3.11 |
| 2026-08-27 | -3.02 |
| 2026-08-26 | -3.02 |
| 2026-08-25 | -2.87 |
| 2026-08-24 | -2.60 |
| 2026-08-21 | -3.45 |
| 2026-08-20 | -3.56 |
| 2026-08-19 | -3.87 |
| 2026-08-18 | -3.57 |
| 2026-08-17 | -3.65 |
| 2026-08-14 | -3.47 |
| 2026-08-13 | -3.43 |
| 2026-08-12 | -3.52 |
| 2026-08-11 | -3.43 |
| 2026-08-10 | -3.36 |
| 2026-08-07 | -3.45 |
| 2026-08-06 | -3.63 |
| 2026-08-05 | -3.38 |
| 2026-08-04 | -3.32 |
| 2026-08-03 | -3.21 |
| 2026-07-31 | -3.12 |
| 2026-07-30 | -3.26 |
| 2026-07-29 | -3.10 |
| 2026-07-28 | -3.09 |
| 2026-07-27 | -3.13 |
| 2026-07-24 | -3.13 |
| 2026-07-23 | -3.30 |
| 2026-07-22 | -3.29 |